1Dupre A, Gagniere J, Chen Y, et al. Management of synchronous colorectal liver metastases [ J ]. Bull Cancer, 2013,100 ( 4 ) : 363 - 71.
2Correa-Gallego C, Fong Y, Gonen M, et al. A retrospective com- parison of microwave ablation vs radiofrequency ablation for color- ectal cancer hepatic metastases [ J ]. Ann Surg 0ncol,2014, 21 ( 13 ) :4278 - 83.
3Dromain C, de Baere T, Elias D, et al. Hepatic tumors treated with pereutaneous radio-frequency ablation: CT and MR imaging follow-up [J]. Radiology, 2002, 223( 1 ) :255 -62.
4Manfredi S, Lepage C, Hatem C, et al. Epidemiology and man-agement of liver metastases from colorectal cancer[J]. Ann Surg, 2006, 244 ( 2 ) :254 - 9.
5Gomez Portilla A, Cendoya I, Olabarria I, et ah The European contribution to "Sugarbaker protocol" for the treatment of colorec- tal peritoneal carcirtomatosis [ J ]. Rev Esp Enferm Dig, 2009,101 (2) :97 -102, 103 -6.
6Pathak S, Jones R, Tang J M, et ah Ablative therapies for color- ectal liver metastases: a systematic review [ J ]. Colorectal Dis, 2011, 13(9) :e252 -65.
7Seki T, Wakabayashi M, Nakagawa T, et al. Ultrasonically guided percutaneous microwave coagulation therapy for small hepa- tccellular carcinoma [ J ]. Cancer, 1994, 74 (3) :817 - 25.
8Liang P, Yu J, Yu X L, et al. Percutaneous cooled-tip microwave ablation under ultrasound guidance for primary liver cancer: a mul-ticentre analysis of 1363 treatment-naive lesions in 1 007 patients in China [J]. Gut, 2012, 61(7) :1100 -1.
9Groeschl R T, Pilgrim C H, Hanna E M, et al. Microwave abla- tion for hepatic malignancies: a multi-institutional analysis [ J ]. Ann Surg, 2014, 259(6):1195-200.
10Pathak S, Jones R, Tang J M, et al. Ablative therapies for color- ectal liver metastases : a systematic review [ J ]. Coloreetal Dis, 2011, 13(9) :e252 -65.
